Ronald van der Geest shares his experience as a speaker
Fast-track drug development: taking the highway or the roundabout? In a race against time, costs and competitors, the pharmaceutical industry finds itself at a crossroads. As the world demands faster…
3D-PharmXchange and CR2O are celebrating and securing the successful ongoing collaboration
A successful drug development strategy is a well-designed and dynamic process. Making sure regulatory requirements are embedded from the start, is key. From pre-clinical all the way to registration, a…
2023 Conferences & Events
3D-PharmXchange will be attending, exhibiting and/or presenting at the following conferences and events in 2023: Click on the event name for more information. Event Date(s) Location Exhibitor/Attendee World ADC March…
Leadership At Treeway
In 2013, Inez de Greef – van der Sandt was appointed as CEO for our client Treeway, a biotechnology company with a mission to develop therapies to cure ALS. Treeway…
Drug Development Strategy: The Treeway Story
The valley of death is often mentioned when talking about drug development. It’s the place where most biotech companies do not survive. Not Treeway, a small Dutch biotech company that…